The best indicator for Procter & Gamble (PG)
We backtested 20 indicators across daily, weekly and hourly charts on real Procter & Gamble (PG) history. Here's what actually worked — risk-adjusted, out-of-sample, with costs.
WaveTrend (8/6/4)
On the weekly chart, this is the strongest risk-adjusted edge we found for Procter & Gamble (PG) over ~64.7 years — trailing buy-and-hold by 4.7% CAGR.
The winner on each chart
Every indicator, ranked
Ranked by Sharpe (risk-adjusted return). Hypothetical, fees included.
| # | Indicator | TF | CAGR | Sharpe | Max DD | Win | Trades | vs B&H |
|---|---|---|---|---|---|---|---|---|
| 1 | WaveTrend (8/6/4) ✓ | Weekly | 5.7% | 0.54 | -24.7% | 83.0% | 47 | -4.7% |
| 2 | EMA 20/50 Cross ✓ | Weekly | 6.9% | 0.47 | -65.2% | 58.3% | 24 | -3.5% |
| 3 | EMA 50/200 Cross ✓ | Daily | 6.9% | 0.46 | -60.7% | 50.0% | 40 | -3.6% |
| 4 | Williams %R ✓ | Weekly | 3.9% | 0.4 | -23.1% | 80.8% | 78 | -6.5% |
| 5 | EMA 20/50 Cross ✓ | Daily | 5.0% | 0.39 | -49.0% | 38.8% | 152 | -5.5% |
| 6 | Donchian Midline ✓ | Weekly | 5.0% | 0.39 | -32.5% | 44.8% | 183 | -5.5% |
| 7 | SMA 50/200 Cross ✓ | Daily | 5.1% | 0.37 | -69.9% | 46.7% | 45 | -5.3% |
| 8 | WaveTrend (8/6/4) ✓ | Daily | 4.5% | 0.37 | -48.8% | 69.1% | 246 | -6.0% |
| 9 | MACD ✓ | Weekly | 4.1% | 0.37 | -39.7% | 52.1% | 146 | -6.4% |
| 10 | Stochastic ✓ | Daily | 3.9% | 0.35 | -48.3% | 72.7% | 311 | -6.6% |
| 11 | CCI ✓ | Weekly | 3.2% | 0.35 | -28.9% | 82.1% | 56 | -7.2% |
| 12 | Williams %R ✓ | Daily | 3.8% | 0.34 | -48.4% | 71.9% | 423 | -6.6% |
| 13 | Holy Grail Confluence ✓ | Daily | 3.5% | 0.33 | -49.5% | 78.0% | 91 | -7.0% |
| 14 | RSI Trend (>50) | Weekly | 4.0% | 0.33 | -53.9% | 46.0% | 187 | -6.4% |
✓ = held up out-of-sample. Hypothetical, costs included. See methodology.
For Procter & Gamble (PG), WaveTrend (8/6/4) on the weekly timeframe gave the best balance of return and risk in our test. It still trailed buy-and-hold on raw return — but remember: this is a hypothetical backtest of a standard rule, not a recommendation. Markets change. See the methodology and disclaimer.
More stock
Get the weekly edge report
The best-performing indicator per asset, what changed this week, and the honest caveats — straight to your inbox.